Medicare Program; Meeting of the Advisory Board on the Demonstration of a Bundled Case-Mix Adjusted Payment System for End-Stage Renal Disease Services, 15343 [05-5920]

Agencies

• Centers for Medicare & Medicaid Services
• DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 70, Number 57 (Friday, March 25, 2005)]
[Notices]
[Page 15343]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-5920]



[[Page 15343]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

[CMS-5033-N3]


Medicare Program; Meeting of the Advisory Board on the 
Demonstration of a Bundled Case-Mix Adjusted Payment System for End-
Stage Renal Disease Services

AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice announces the second public meeting of the 
Advisory Board on the Demonstration of a Bundled Case-Mix Adjusted 
Payment System for End-Stage Renal Disease (ESRD) Services. Notice of 
this meeting is required by the Federal Advisory Committee Act (5 
U.S.C. App. 2, section 10(a)(1) and (a)(2)). The Advisory Board will 
provide advice and recommendations with respect to the establishment 
and operation of the demonstration mandated by section 623(e) of the 
Medicare Prescription Drug, Improvement, and Modernization Act of 2003.

DATES: The meeting is on April 13, 2005 from 9 a.m. to 5 p.m., eastern 
standard time.
    Special Accomodations: Persons attending the meeting who are 
hearing or visually impaired or have a condition that requires special 
assistance or accommodations are asked to notify Pamela Kelly by April 
6, 2005 by e-mail at ESRDAdvisoryBoard@cms.hhs.gov or by telephone at 
(410) 786-2461.

ADDRESSES: The meeting will be held at the Hyatt Regency, 300 Light 
Street, Baltimore, MD 21202.
    Attendance is limited to the space available, so seating will be on 
a first come, first served basis.
    Web site: Up-to-date information on this meeting is located at 
https://www.cms.hhs.gov/faca/esrd.
    Hotline: Up-to-date information on this meeting is located on the 
CMS Advisory Committee Hotline at 1 (877) 449-5659 (toll free) or in 
the Baltimore area at (410) 786-9379.

FOR FURTHER INFORMATION CONTACT: Pamela Kelly by e-mail at 
ESRDAdvisoryBoard@cms.hhs.gov or telephone at (410) 786-2461.

SUPPLEMENTARY INFORMATION: On June 2, 2004, we published a Federal 
Register notice requesting nominations for individuals to serve on the 
Advisory Board on the Demonstration of a Bundled Case-Mix Adjusted 
Payment System for End-Stage Renal Disease (ESRD) Services. The June 2, 
2004 notice also announced the establishment of the Advisory Board and 
the signing by the Secretary on May 11, 2004 of the charter 
establishing the Advisory Board. On January 28, 2005, we published a 
Federal Register notice (70 FR 4132) announcing the appointment of 
eleven individuals to serve as members of the Advisory Board on the 
Demonstration of a Bundled Case-Mix Adjusted Payment System for ESRD 
Services, including one individual to serve as co-chairperson, and one 
additional co-chairperson, who is employed by CMS. The first public 
meeting of the Advisory Board was held on February 16, 2005. This 
notice announces the second public meeting of this Advisory Board.

I. Topics of the Advisory Board Meeting

    The Advisory Board on the Demonstration of a Bundled Case-Mix 
Adjusted Payment System for ESRD Services will study and make 
recommendations on the following issues:
     The drugs, biologicals, and clinical laboratory tests to 
be bundled into the demonstration payment rates.
     The method and approach to be used for the patient 
characteristics to be included in the fully case-mix adjusted 
demonstration payment system.
     The manner in which payment for bundled services provided 
by non-demonstration providers should be handled for beneficiaries 
participating in the demonstration.
     The feasibility of providing financial incentives and 
penalties to organizations operating under the demonstration that meet 
or fail to meet applicable quality standards.
     The specific quality standards to be used.
     The feasibility of using disease management techniques to 
improve quality and patient satisfaction and reduce costs of care for 
the beneficiaries participating in the demonstration.
     The selection criteria for demonstration organizations.

II. Procedure and Agenda of the Advisory Board Meeting

    This meeting is open to the public. The Advisory Board will hear 
background presentations from CMS. The Advisory Board will then 
deliberate openly on the general topic and will make recommendations on 
specific topics for future meetings. The Advisory Board will also allow 
a 30-minute opportunity for public remarks or presentations. Interested 
parties may speak or ask questions during this time. Comments may be 
limited by the time available. Written questions should be submitted by 
April 6, 2005 to ESRDAdvisoryBoard@cms.hhs.gov. Parties may also submit 
written comments following the meeting to the contact listed under the 
FOR FURTHER INFORMATION CONTACT section of this notice.

    Authority: 5 U.S.C. App. 2, section 10(a). (Catalog of Federal 
Domestic Assistance Program No. 93.774, Medicare--Supplementary 
Medical Insurance Program)

    Dated: March 10, 2005.
Mark B. McClellan,
Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. 05-5920 Filed 3-24-05; 8:45 am]
BILLING CODE 4120-01-P